levodopa has been researched along with kainic acid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Carolei, A; Del Castillo, G | 1 |
| Cho, F; Kanazawa, I; Kimura, M; Murata, M; Tanaka, Y | 1 |
| Kanazawa, I | 1 |
| Carboni, S; Gessa, GL; Pani, L; Portas, CM; Rossetti, ZL | 1 |
| Cho, F; Kanazawa, I; Tanaka, Y | 1 |
| Godlevskiĭ, LS; Kryzhanovskiĭ, GN; Makul'kin, RF; Rozhkov, VS; Shandra, AA | 1 |
| Gomez-Gonzales, M; Murer, G; O'Donnell, P; Pazo, JH; Tumilasci, OR | 1 |
| Concas, A; Porceddu, ML | 1 |
| Bannon, MJ; Braszko, JJ; Bunney, BS; Roth, RH | 1 |
| Hefti, F; Liebman, J; Melamed, E; Pettibone, DJ; Wurtman, RJ | 1 |
| Hefti, F; Melamed, E; Wurtman, RJ | 1 |
| Lee, T; Teo, WL; Wong, PT | 1 |
| Kanazawa, I; Kimura, M; Murata, M | 1 |
| Goshima, Y; Kawashima, K; Misu, Y; Miyamae, T; Ohshima, E; Shibata, T; Shimizu, M; Suzuki, F | 1 |
| Caccia, C; Calabresi, M; Curatolo, L; Faravelli, L; Fariello, RG; Maestroni, S; Maj, R; Salvati, P | 1 |
| Alvarez-Erviti, L; Barroso-Chinea, P; Blesa, FJ; Guridi, J; Lanciego, JL; Obeso, JA; Rodríguez-Oroz, MC; Smith, Y | 1 |
| Bishop, SC; Fukui, M; Kang, KS; Wen, Y; Yamabe, N; Zhu, BT | 1 |
| Fukui, M; Kang, KS; Wen, Y; Yamabe, N; Zhu, BT | 1 |
| Auburger, G; Dehorter, N; Gispert, S; Hammond, C; Klinkenberg, M; Lopez, C; Lozovaya, N; Mdzomba, BJ; Michel, FJ; Tsintsadze, T; Tsintsadze, V | 1 |
| Kelsey, JE; Neville, C | 1 |
3 review(s) available for levodopa and kainic acid
| Article | Year |
|---|---|
[Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
Topics: Amphetamine; Antipsychotic Agents; Brain; Butyrophenones; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Levodopa; Lithium; Neurotransmitter Agents; Phenothiazines; Sympatholytics; Tetrabenazine | 1979 |
[Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
Topics: Animals; Disease Models, Animal; Dopamine; Haplorhini; Huntington Disease; Kainic Acid; Levodopa | 1990 |
Safinamide: from molecular targets to a new anti-Parkinson drug.
Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Brain Ischemia; Disease Models, Animal; Gerbillinae; Humans; Kainic Acid; Levodopa; Mice; MPTP Poisoning; Neurons; Rats; Veratridine | 2006 |
18 other study(ies) available for levodopa and kainic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Choreic movements in the macaque monkey induced by kainic acid lesions of the striatum combined with L-dopa. Pharmacological, biochemical and physiological studies on neural mechanisms.
Topics: Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Chorea; Corpus Striatum; Electrophysiology; Kainic Acid; Levodopa; Macaca fascicularis; Male; Methamphetamine; Movement; Nervous System; Neurons; Neurotransmitter Agents; Volition | 1990 |
Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release?
Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Corpus Striatum; Dextroamphetamine; Dialysis; Dopamine; Extracellular Space; Kainic Acid; Levodopa; Male; Pargyline; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Synapses; Synaptic Transmission | 1990 |
'Choreic' movement induced by unilateral kainate lesion of the striatum and L-DOPA administration in monkey.
Topics: Animals; Chorea; Corpus Striatum; Dopamine; Kainic Acid; Levodopa; Macaca fascicularis; Male; Substantia Nigra; Synaptic Transmission | 1986 |
[Modelling of the parkinsonian syndrome by the administration of kainic acid into the caudate nucleus].
Topics: Animals; Caudate Nucleus; Disease Models, Animal; Drug Evaluation, Preclinical; Electrodes, Implanted; Electroencephalography; Female; Injections; Kainic Acid; Levodopa; Male; Parkinson Disease, Secondary; Rats; Time Factors; Trihexyphenidyl | 1987 |
The sialagogue response of striatal dopamine receptors to L-dopa is not influenced by castration or chronic estrogen treatment.
Topics: Animals; Behavior, Animal; Corpus Striatum; Denervation; Estradiol; Female; Kainic Acid; Levodopa; Ovariectomy; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salivary Glands; Time Factors | 1986 |
Partial protection by CDP-choline against kainic acid-induced lesion in the rat caudate nucleus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Choline; Cytidine Diphosphate Choline; Dopamine; Kainic Acid; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Time Factors | 1985 |
Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
Topics: Animals; Corpus Striatum; Dopamine; Kainic Acid; Levodopa; Male; Pyrrolidines; Rats; Substantia Nigra; Synaptic Transmission; Time Factors | 1981 |
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain Diseases; Corpus Striatum; Dopamine; Glutamate Decarboxylase; Kainic Acid; Levodopa; Male; Neurons; Parkinson Disease; Rats; Serotonin | 1981 |
The site of dopamine formation in rat striatum after L-dopa administration.
Topics: Animals; Corpus Striatum; Dopamine; Hydroxydopamines; Kainic Acid; Levodopa; Male; Rats; Substantia Nigra | 1981 |
A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxydopamines; Hydroxyindoleacetic Acid; Kainic Acid; Levodopa; Male; Microdialysis; Neurons; Putamen; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin; Tyramine | 1993 |
Roles of dopamine and its receptors in generation of choreic movements.
Topics: Afferent Pathways; Animals; Brain Mapping; Cerebral Cortex; Choline O-Acetyltransferase; Chorea; Corpus Striatum; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Kainic Acid; Levodopa; Macaca; Neurons; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Substantia Nigra; Synapses; Tyrosine 3-Monooxygenase | 1993 |
Some interactions of L-DOPA and its related compounds with glutamate receptors.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Kainic Acid; Levodopa; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Xenopus laevis | 1999 |
Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dyskinesia, Drug-Induced; Functional Laterality; Intralaminar Thalamic Nuclei; Kainic Acid; Levodopa; Macaca fascicularis; Male; Parkinsonian Disorders; Stereotaxic Techniques | 2008 |
Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.
Topics: Animals; Biological Products; Catechin; Catechol O-Methyltransferase Inhibitors; Cell Death; Cell Line; Enzyme Inhibitors; Hippocampus; Humans; Kainic Acid; Levodopa; Male; Methylation; Mice; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2010 |
Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antiparkinson Agents; Carbidopa; Catechin; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Disease Models, Animal; Excitatory Amino Acid Agonists; Fluoresceins; Glial Fibrillary Acidic Protein; Hippocampus; Hydroxybenzoates; In Vitro Techniques; Kainic Acid; Levodopa; Male; Methylation; Mice; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Reserpine; Time Factors; Tyrosine | 2013 |
Subthalamic lesion or levodopa treatment rescues giant GABAergic currents of PINK1-deficient striatum.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Electric Conductivity; Excitatory Amino Acid Agonists; Female; gamma-Aminobutyric Acid; Immunohistochemistry; Kainic Acid; Levodopa; Male; Mice; Mice, Knockout; Neurons; Parkinsonian Disorders; Patch-Clamp Techniques; Protein Kinases; Subthalamic Nucleus | 2012 |
The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease.
Topics: Animals; Anti-Bacterial Agents; Antiparkinson Agents; Ceftriaxone; Central Nervous System Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Transporter 2; Forelimb; Kainic Acid; Levodopa; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats, Long-Evans | 2014 |